The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Main Page: Medical News Roundups and more Medical Device and Biotech/Pharmaceutical News Medical Meetings and Conventions Calendar Message Boards for Medical Sales and Marketing Professionals, Distributors and Independent Sales Reps in Devices, Biopharmaceuticals and Diagnostics Medical Device Companies, Biotech/Pharmaceutical Companies, Distributors and Independent Sales Reps Members sections: News Roundups, News Archives, SuperSearch, Directory of Medical Sales and Marketing Professionals
Healthcare Sales & Marketing Network celebrates twelve years serving the medical device, biopharmaceutical and diagnostics community!
Share/Bookmark

 
 Roundups:   Bio/Pharma | Devices | Diagnostics | Cardiology | Oncology | Neuro | Ortho | FDA | Personnel | M&A
Generics | Interventional | Radiology | Regenerative | Endocrinology | Monitoring | Venture Capital


  
   
 Healthcare Industry NewsFeed
Search hints >>    
     
 

 

 Search for:  "perindopril erbumine" 

Lupin Receives U.S. FDA Approval For Perindopril Erbumine Tablets
HSMN NewsFeed, 28 Jan 2010:   Biopharmaceuticals, Generics, FDA
[Lupin Pharmaceuticals, Perindopril Erbumine, ACEON, Solvay Pharmaceuticals]

CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets
HSMN NewsFeed, 11 Oct 2006:   Biopharmaceuticals
[CV Therapeutics, Solvay Pharmaceuticals, ACEON, perindopril erbumine]

CV Therapeutics Receives Notices of Allowance From U.S. Patent and Trademark Office and European Patent Office for Drug-Eluting Stent Technology
HSMN NewsFeed, 5 Oct 2006:   Devices, Interventional Cardiology
[CV Therapeutics, drug eluting stent, stent coating]

CV Therapeutics Completes MERLIN TIMI-36 Study
HSMN NewsFeed, 26 Sep 2006:   Biopharmaceuticals, Cardiology
[CV Therapeutics, Ranexa, ranolazine, MERLIN TIMI-36, acute coronary syndromes]

CV Therapeutics Announces MERLIN TIMI-36 Study to Continue as Planned Based on Final Scheduled DSMB Meeting
HSMN NewsFeed, 7 Jul 2006:   Biopharmaceuticals, Cardiology
[CV Therapeutics, Ranexa, ranolazine, TIMI-36 study]

CV Therapeutics Acquires Rights to Ranolazine in Asia
HSMN NewsFeed, 22 Jun 2006:   Biopharmaceuticals, Licensing
[CV Therapeutics, Roche , ranolazine]

JACC Publishes ERICA Trial Results Showing Ranexa(R) Reduces Angina Frequency and Nitroglycerin Consumption
HSMN NewsFeed, 19 Jun 2006:   Biopharmaceuticals, Cardiology
[CV Therapeutics, ERICA trial, Ranolazine, Ranexa , angina]

PTC Therapeutics and CV Therapeutics Announce Collaboration and License Arrangement
HSMN NewsFeed, 12 Jun 2006:   Biopharmaceuticals, Licensing
[PTC Therapeutics, CV Therapeutics]

CV Therapeutics Completes Enrollment of Second Regadenoson Phase 3 Trial
HSMN NewsFeed, 7 Jun 2006:   Biopharmaceuticals, Cardiology
[CV Therapeutics, regadenoson]

Angina Patients Cost Managed Care Over Twice as Much as Coronary Artery Disease Patients Without Angina
HSMN NewsFeed, 9 May 2006:   Biopharmaceuticals, Cardiology
[CV Therapeutics, angina]

CV Therapeutics Begins Shipments of Ranexa to Wholesalers
HSMN NewsFeed, 10 Mar 2006:   Biopharmaceuticals, Cardiology
[CV Therapeutics, Ranexa, ranolazine]

FDA Approves Ranexa
HSMN NewsFeed, 27 Jan 2006:   Biopharmaceuticals, Cardiology, FDA
[CV Therapeutics, Ranexa, ranolazine]




Members click here for search results from The Network Archive (password required) Additional items found:
The Network Archive contains 9 additional items
matching: perindopril erbumine
<< Members - click the icon at left to display.
 
     
 
     

 

 

 HOME    •    NEWSFEED    •     MEETINGS & CONVENTIONS    •    FORUM    •    LINKS    •    TOP   
Copyright © 1998-2010 The Healthcare Sales & Marketing Network. All rights reserved.
The Healthcare Sales & Marketing Network is a registered trademark of Healthcare Sales & Marketing Network, LLC.
Powered by Redhat Enterprise Linux 4ES